6月12日 - ** 疫苗制造商莫德纳MRNA.O股价下跌2.7%，至27美元
** 莫德纳公司在周三晚些时候举行的一次行业会议上说，该公司正在寻找合作伙伴，对其针对爱泼斯坦-巴氏病毒、水痘带状疱疹病毒和生殖器疱疹的实验性疫苗进行后期研究。
** MRNA表示，它不会独自将实验性疫苗推向后期试验阶段
** 包括本交易日的走势在内，该股今年累计下跌35
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.